Adipose Fatty Acid Oxidation Is Required for Thermogenesis and Potentiates Oxidative Stress-Induced Inflammation  by Lee, Jieun et al.
ArticleAdipose Fatty Acid Oxidation Is Required for
Thermogenesis and Potentiates Oxidative Stress-
Induced InflammationGraphical AbstractHighlightsd Adipose fatty acid oxidation (FAO) is required for cold-
induced thermogenesis
d Adipose FAO is required for agonist-induced thermogenic
gene expression
d Loss of adipose FAO does not alter body weight
d Adipose FAO is required for high-fat-induced oxidative stress
and inflammation.Lee et al., 2015, Cell Reports 10, 266–279
January 13, 2015 ª2015 The Authors
http://dx.doi.org/10.1016/j.celrep.2014.12.023Authors
Jieun Lee, Jessica M. Ellis, Michael J.
Wolfgang
Correspondence
mwolfga1@jhmi.edu
In Brief
In order to understand the contribution of
adipose tissue fatty acid oxidation to
whole-body energy homeostasis, Lee
et al. deleted carnitine
palmitoyltransferase 2 specifically in
adipocytes. They show requirements for
adipocyte fatty acid oxidation in cold-
induced thermogenesis, gene expression
in brown adipocytes, diet-induced
adiposity, oxidative stress, and
inflammation.
Cell Reports
ArticleAdipose Fatty Acid Oxidation Is Required
for Thermogenesis and Potentiates
Oxidative Stress-Induced Inflammation
Jieun Lee,1 Jessica M. Ellis,1,2 and Michael J. Wolfgang1,*
1Department of Biological Chemistry, Center for Metabolism andObesity Research, Johns Hopkins University School of Medicine, Baltimore,
MD 21205, USA
2Present address: Department of Nutrition Science, Purdue University, West Lafayette, IN 47907, USA
*Correspondence: mwolfga1@jhmi.edu
http://dx.doi.org/10.1016/j.celrep.2014.12.023
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARY
To understand the contribution of adipose tissue
fatty acid oxidation to whole-body metabolism, we
generated mice with an adipose-specific knockout
of carnitine palmitoyltransferase 2 (CPT2A/), an
obligate step in mitochondrial long-chain fatty acid
oxidation. CPT2A/mice became hypothermic after
an acute cold challenge, and CPT2A/ brown adi-
pose tissue (BAT) failed to upregulate thermogenic
genes in response to agonist-induced stimulation.
The adipose-specific loss of CPT2 resulted in diet-
dependent changes in adiposity but did not result
in changes in body weight on low- or high-fat diets.
Additionally, CPT2A/ mice had suppressed high-
fat diet-induced oxidative stress and inflammation
in visceral white adipose tissue (WAT); however,
high-fat diet-induced glucose intolerance was not
improved. These data show that fatty acid oxidation
is required for cold-induced thermogenesis in BAT
and high-fat diet-induced oxidative stress and
inflammation in WAT.
INTRODUCTION
Ingestion of a calorically dense diet, generally high in fat con-
tent, coupled with inactivity leads to increased adiposity and
eventual obesity. Obesity in turn is highly correlated with the
development of type 2 diabetes, the metabolic syndrome, and
cardiovascular disease, among others. The molecular mecha-
nisms by which high-fat diets contribute to these pathologies
are not well understood, but several themes have emerged.
Implicated in the etiology and progression of obesity-related
pathologies is oxidative stress, endoplasmic reticulum stress,
and inflammation originating locally at adipose depots but
acting systemically to promote insulin resistance (Glass and
Olefsky, 2012; Hotamisligil, 2010; Keaney et al., 2003; Kusmin-
ski and Scherer, 2012). Reversing or preventing local adipose
tissue inflammation may have beneficial systemic effects
against insulin resistance. Alternatively, strategies to reverse266 Cell Reports 10, 266–279, January 13, 2015 ª2015 The Authorsobesity by increasing adipose energy expenditure have been
suggested to improve systemic obesity-related complications
(Tseng et al., 2010).
Adult mammals have at least two functionally distinct adipose
lineages: unilocular white adipocytes, which function mainly to
store fat, and multilocular brown adipocytes, which function
mainly to burn fat for thermogenesis. Dysfunctional white adi-
pose tissue (WAT) and brown adipose tissue (BAT) have been
implicated in the pathogenesis of obesity and diabetes. BAT is
densely packed with mitochondria and requires fatty acid oxida-
tion to fuel heat generation (Ellis et al., 2010; Guerra et al., 1998;
Ji et al., 2008; Schuler et al., 2005; Tolwani et al., 2005). Although
the oxidation of fatty acids in WAT in the fed state is relatively
low, fasting doubles the rate of white adipocyte fatty acid oxida-
tion and is presumably a major fuel in insulin suppressed states
(Wang et al., 2003). Changing macronutrient metabolism spe-
cifically in adipocytes can lead to changes in adiposity, body
weight, and glucose tolerance (Abel et al., 2001; Ahmadian
et al., 2011; Lodhi et al., 2012; Vernochet et al., 2012). However,
the autonomous contribution of adipose fatty acid oxidation to
obesity and insulin resistance remains unknown.
Mitochondrial long-chain fatty acid b-oxidation requires suc-
cessive carnitine acyltransferases to translocate acyl-coenzyme
As (acyl-CoAs) from the cytoplasm into the mitochondrial matrix
(Wolfgang and Lane, 2006). The initial and rate-setting enzyme,
CPT1, generates acylcarnitines that can traverse the mitochon-
drial membranes via specific transporters. CPT1 is allosterically
inhibited by the rate-determining metabolite in de novo fatty acid
synthesis, malonyl-CoA; therefore, the balance of fatty acid syn-
thesis and oxidation is metabolically coordinated posttransla-
tionally. Once inside the mitochondrial matrix, CPT2 generates
acyl-CoAs from acylcarnitines to initiate the b-oxidation of
long-chain fatty acids to acetyl-CoA. Fatty acids contain an
abundant energy potential, making them ideal for storage during
energy surplus and mobilization during energy deficits. Fatty
acid oxidation efficiently generates energy but can also promote
the generation of reactive oxygen species (ROS). ROS can
potentiate oxidative stress and inflammation, which can impair
insulin sensitivity (Houstis et al., 2006).
Although it is clear that fatty acid oxidation is a critical and
fundamental metabolic endpoint in humans (Longo et al., 2006)
and rodents (Ji et al., 2008; Nyman et al., 2005), it is not clear
Figure 1. Generation of Mice with an Adi-
pose-Specific KO of CPT2
(A) Gene targeting strategy for the Cpt2 gene.
Triangles represent loxP sites.
(B) mRNA for Cpt2 in adipose depots and liver of
control and CPT2A/ mice (n = 8).
(C) Western blot for CPT2 in BAT of control,
CPT2A/+, and CPT2A/ mice.
(D) Oxidation of 1-14C-oleic acid to 14CO2 in control
and CPT2A/ adipose depot explants (n = 5).
(E) Oxidation of 1-14C-oleic acid or 1-14C-ligno-
ceric acid to 14CO2 in control and CPT2 KO MEFs
(n = 5).
(F) Acylcarnitine profile of iWAT in control and
CPT2A/ mice (n = 8).
Data are expressed as mean ± SEM. *p < 0.05;
**p < 0.001; N.S., not significant. Open bars
represent control, and black bars represent loss of
CPT2.how adipocyte fatty acid oxidation affects whole-body meta-
bolism in an autonomous manner. Therefore, we generated a
conditional loss-of-function allele for CPT2, an obligate step in
mitochondrial long-chain fatty acid b-oxidation that is encoded
by a single gene. Here we show that adipose tissue fatty acid
oxidation is required not only for acute cold adaptation but
also for the induction of thermogenic genes in BAT. The loss of
adipose fatty acid oxidation altered adiposity in a diet-depen-
dent manner but did not lead to diet-induced changes in body
weight. Furthermore, we show that in WAT, the loss of fatty
acid oxidation reduces high-fat-induced oxidative stress and
inflammation but does not alter the progression of obesity or
glucose intolerance.Cell Reports 10, 266–279RESULTS
Generation of Mice with an Adipose
Tissue-Specific Deletion of CPT2
Mitochondrial long-chain fatty acid oxi-
dation requires sequential carnitine acyl-
transferases to translocate acyl-CoAs
into the mitochondrial matrix. The regu-
lated and rate setting enzyme, CPT1, is
encoded by multiple isoenzymes that
can functionally compensate in some tis-
sues (Haynie et al., 2014). Therefore, to
generate a mouse model to assess the
tissue-specific roles and requirements of
fatty acid oxidation, we generated a con-
ditional loss-of-function allele for CPT2,
an enzyme required in mitochondrial
long-chain fatty acid b-oxidation that is
encoded by a single gene. C57BL/6 em-
bryonic stem cells were used to target
loxP recombination sites surrounding
exon 4 of the Cpt2 gene (Figure 1A).
Exon 4 encompasses approximately
one-third of the protein coding sequence
including all of the critical catalytic resi-dues (Hsiao et al., 2006). Loss of exon 4 is predicted to addi-
tionally cause a frameshift in the remaining exons. To produce
mice with a loss of CPT2 specifically in adipocytes, we bred
CPT2lox/lox mice to adipocyte specific adiponectin-Cre trans-
genic mice (Eguchi et al., 2011). The resulting adipose-specific
CPT2 knockout (KO) mice, CPT2A/, have a loss of Cpt2
mRNA in all adipose depots examined (Figure 1B). Furthermore,
CPT2 protein is substantially reduced in BAT of CPT2A/ mice
(Figure 1C). As expected, ex vivo gonadal WAT (gWAT), inguinal
WAT (iWAT), and BAT explants derived from CPT2A/mice had
a greatly suppressed ability to oxidize radiolabeled 1-14C-oleic
acid (Figure 1D). Long chain mitochondrial fatty acid b-oxidation
cannot proceed in the absence of CPT2. The remaining oxidation, January 13, 2015 ª2015 The Authors 267
of oleic acid in tissues was presumably due to either peroxisomal
fatty acid oxidation or oxidation in nonparenchymal cells within
the adipose depots. To test this directly, we derived and immor-
talized mouse embryonic fibroblasts (MEFs) from CPT2lox/lox
embryos and infected them with a control or Cre recombinase
expressing virus. The oxidation of 1-14C-oleic acid in CPT2lox/lox
MEFs was severely blunted by incubating cells with a large
dose (100 mM) of the mitochondrial fatty acid oxidation inhibitor
etomoxir. The genetic loss of CPT2 in MEFs suppressed oleic
acid oxidation to the same degree as etomoxir (Figure 1E). How-
ever, the oxidation of the very long chain lignoceric acid (C24:0),
which is oxidized mainly in peroxisomes, was not significantly
changed (Figure 1E). Therefore, the deletion of CPT2 represents
an effective strategy for inhibiting long chain mitochondrial fatty
acid b-oxidation.
To determine how the loss of CPT2 alters white adipose fatty
acid oxidative metabolites, we measured the steady-state con-
centration of carnitine and acyl-carnitine species in iWAT of con-
trol and CPT2A/mice. Although CPT2 deficiency results in the
inability to utilize long chain acyl-carnitines and people with
CPT2 mutations are diagnosed by the elevation of these metab-
olites in serum, CPT2A/mice did not have increased long chain
acyl-carnitine species in iWAT. Instead, CPT2A/ iWAT had a
strong trend toward suppressed free carnitine and acetyl-carni-
tine and statistically significant reductions in several short chain
acyl-carnitines (Figure 1F). We conclude that long chain acyl-
carnitines do not build up in WAT but are readily transported
out of the adipocyte resulting in a tissue specific carnitine defi-
ciency due to the inability to properly recycle carnitine in
CPT2A/ WAT. In summary, we have generated mice with an
adipose-specific defect in mitochondrial long-chain fatty acid
oxidation that is mediated by the loss of an obligate noncompen-
satory step in fatty acid oxidation.
Adipose Fatty Acid Oxidation Is Required for
Cold-Induced Thermogenesis
BAT is essential for heat generation during an acute cold expo-
sure in perinatal and adult mammals (Kozak, 2010; Lowell et al.,
1993; Tseng et al., 2010). The requirement of fatty acid oxida-
tion during cold thermogenesis is made evident by cold-intol-
erant phenotypes of whole-body KO mouse models of the
acyl-CoA dehydrogenase enzymes (Guerra et al., 1998; Schuler
et al., 2005; Tolwani et al., 2005). To determine the autonomous
requirement of adipose fatty acid oxidation during adaptive
thermogenesis, we placed 12-week-old control and CPT2A/
female mice at 4C and measured their body temperature
over 3 hr. Although all of the mice visibly shivered, cold into-
lerance was evident in CPT2A/ mice, reaching critical hypo-
thermia (30C) within 3 hr (Figure 2A). The body weights of
12-week-old female CPT2A/ mice were not different (Fig-
ure 2B). Upon dissection, CPT2A/ interscapular BAT was
visibly lipid laden, displaying a milky appearance in contrast
to the dark brown color of control BAT (Figure 2C). Histologic
evaluation demonstrated increased lipid droplet accumulation
that did not dissipate upon cold stimulation (Figure 2D). Consis-
tent with these morphologic changes, cold-exposed CPT2A/
BAT maintained 3-fold increase in triglyceride content com-
pared to BAT from control mice (Figure 2E). Evaluation of268 Cell Reports 10, 266–279, January 13, 2015 ª2015 The Authorsserum metabolites showed normal responses of serum glu-
cose, ketone bodies, and triglycerides to cold stimulation in
CPT2A/ mice. However, compared to controls, CPT2A/
mice had increased serum free fatty acids and decreased glyc-
erol during cold stimulation, likely due to their inability to utilize
the mobilized fatty acids in CPT2 null BAT (Figure 2F). These
data show that adipose fatty acid oxidation is required for
acute cold-induced thermogenesis.
BAT Fatty Acid Oxidation Is Required for
Agonist-Induced Thermogenic Gene Expression
To understand the transcriptional control of BAT metabolism in
CPT2A/mice, we determined the expression of fatty acid cata-
bolic and anabolic genes. After a 3 hr cold stimulation, the fatty
acid oxidative genes Acox1, Cpt1b, and Lcad were suppressed
in CPT2A/ BAT (Figure 3A). Malonyl-CoA decarboxylase
(Mlycd), which decarboxylates malonyl-CoA and therefore disin-
hibits CPT1, was greatly suppressed in both basal and cold-
stimulated CPT2A/ BAT. Additionally, fatty acid biosynthetic
genes Pcx, Acaca, and Elovl6 were suppressed after a 3 hr
cold stimulation in CPT2A/ BAT compared to controls (Fig-
ure S1A). These data suggest that the loss of fatty acid oxidation
in BAT feeds back to inhibit genes in fatty acid oxidation. To bet-
ter understand the role of fatty acid oxidation on thermogenic
programing in BAT, we measured the transcriptional response
of BAT to cold stimulation. The canonical cold-induced genes
Ucp1, Pgc1a, and Dio2 were induced robustly in BAT of control
mice after 3 hr at 4C but were unresponsive in CPT2A/ BAT
(Figure 3B). In fact, Ucp1 and Dio2 were suppressed con-
stitutively even at room temperature. Ucp1 and Pgc1a are ther-
mogenic genes regulated by adrenergic signaling upon cold
exposure. Therefore, we determined if CPT2A/ BAT was
responsive to adrenergic stimulation by injecting CPT2A/ and
control mice with the selective b3-adrenergic agonist CL-
316243 (10 mg/kg) and collected BAT 3 hr later. Unlike the con-
trol, CPT2A/ BAT elicited no increase in the mRNA abundance
of Ucp1 or Pgc1a (Figure 3B). This suggests a strong defect in
CPT2A/ BAT thermogenic gene expression.
To determine where in the adrenergic signaling pathway
CPT2A/ BAT was impaired, we collected control and
CPT2A/ BAT explants and stimulated them ex vivo with
10 mM CL-316243, the b-adrenergic agonist isoproterenol, or
the adenylyl cyclase activator forskolin, in the presence of
200 mM fatty acids (2:1 oleate:palmitate). All of these activators
robustly induced Ucp1 in control explants; however, CPT2A/
BAT was unable to induceUcp1 (Figure 3C). These data suggest
that the defect in cold-induced thermogenic gene expression is
mediated downstream of the adrenergic receptor.
To determine if CPT2A/ BAT was activating signaling down-
stream of adrenergic stimulation, we probed for protein kinase A
(PKA) targets of adrenergic signaling after a 30 min stimulation
with 10mg/kg CL-316243 in vivo. Utilizing a PKA phosphorylated
substrate specific antibody, both control and CPT2A/ BAT
showed robust CL-316243 mediated phosphorylation (Fig-
ure 3D). Additionally, cAMP response element-binding protein
(CREB) phosphorylation, the canonical transcription factor
downstream of adrenergic stimulation, elicited a robust phos-
phorylation in both control and CPT2A/ BAT (Figure 3E). These
Figure 2. Adipose Fatty Acid Oxidation Is
Required for Acute Cold-Induced Thermo-
genesis
(A) Body temperature of control and CPT2A/
mice subjected to a 3 hr cold challenge (n =
10–13).
(B) Body weights of 12-week-old female control
and CPT2A/ mice (n = 22-26).
(C) Gross morphology of control and CPT2A/
BAT after 2 hr of cold exposure.
(D) Hematoxylin and eosin (H&E)-stained sections
of BAT from control and CPT2A/ mice at 21C
and 3 hr at 4C. Scale bar is 100 mM.
(E) Triglyceride content of BAT of control and
CPT2A/ mice after 3 hr at 4C (n = 5).
(F) Serum metabolites in control and CPT2A/
mice at 21C and 3 hr at 4C (n = 8).
Data are expressed as mean ± SEM. *p < 0.001.
Open bars represent control and black bars
represent loss of CPT2.data show that CPT2A/ BAT can activate adrenergic signaling
and phosphorylation of downstream targets such as CREB. This
suggests the defect in agonist-induced thermogenic gene
expression is likely at the level of transcriptional regulation.
Taken together, these experiments show that CPT2A/ BAT is
resistant to agonist-induced thermogenic gene expression and
further suggest that fatty acid oxidation in BAT is coupled to
agonist-induced transcription.
CPT2A/ Mice Are Defective in Environmental
Temperature Adaptation
Mammals can dramatically alter their physiology to adapt to the
ambient temperature. Cold acclimation of UCP1KO mice is suf-
ficient to rescue their acute cold intolerance (Golozoubova et al.,
2001; Ukropec et al., 2006). To test the role of adipose fatty acid
oxidation on this adaptation, we cold acclimatized CPT2A/
mice to 15C and then subjected them to an acute 4C cold chal-Cell Reports 10, 266–279,lenge. At 15C, CPT2A/ and control
mice had lower body temperatures
(35.5C) that upon cold challenge ini-
tially rose rapidly. However, CPT2A/
mice could not maintain body tempera-
ture and after 4 hr reached critical hypo-
thermia (Figure 3F). Again, Ucp1 and
Dio2mRNA abundance was suppressed
in CPT2A/ BAT (Figure 3G). This sug-
gests that adipose fatty acid oxidation
has additional roles other than merely
activating UCP1 in BAT. Next, we asked
if the inhibition of agonist-induced ther-
mogenic gene expression at 21C and
15C was due to tonic activation of ther-
mogenic signaling and therefore consti-
tutively inhibited via negative feedback.
To eliminate tonic basal thermogenic
signaling, we acclimatized CPT2A/
and control mice to a thermoneutral envi-
ronment (30C). We then injected the
mice with 10 mg/kg CL-316243 or vehicle and collected BAT
3 hr later. Thermoneutral acclimatization did not improve
agonist-induced thermogenic gene expression in CPT2A/
mice. In fact, the difference between control and CPT2A/
mice was further exacerbated, suggesting that the transcrip-
tional defect is not due to tonic inhibition but is a primary defect
(Figure 3H). These data show that adipose fatty acid oxidation is
critical for thermal adaptation.
Loss of Adipose Fatty Acid Oxidation Disrupts
Mitochondrial Homeostasis in BAT
The lack of agonist-induced Pgc1a expression, a gene key to
mitochondrial biogenesis, prompted us to examine mitochon-
drial proteins and mitochondrial density in CPT2A/ BAT.
Several mitochondrial proteins were suppressed in CPT2A/
BAT under basal (21C) conditions, including ACO2 and
MCAD (Figures 3I and S1). These changes were exacerbatedJanuary 13, 2015 ª2015 The Authors 269
Figure 3. Adipose Fatty Acid Oxidation Is Required for Agonist-Induced Thermogenic Gene Expression and Mitochondrial Homeostasis
(A) mRNA expression of fatty acid oxidative genes in BAT of control and CPT2A/ mice at 21C or after 3 hr at 4C (n = 8).
(B) mRNA expression of Ucp1, Pgc1a, and Dio2 in BAT of control and CPT2A/mice at 21C (n = 8), after 3 hr at 4C (n = 8), or 3 hr after injection with 10 mg/kg
CL-316243 (n = 5).
(C) mRNA expression of Ucp1 in BAT explants treated with 10 mM CL-316243, isoproterenol, or forskolin (n = 5).
(D) Western blot for PKA phosphorylated substrates in BAT of control and CPT2A/ mice treated with 10 mg/kg CL-316243 for 30 min in vivo.
(E) Western blot for P-CREB (Ser-133) in BAT of control and CPT2A/ mice treated with 10 mg/kg CL-316243 for 30 min in vivo.
(F) Body temperature of control and CPT2A/ mice acclimatized to 15C and subjected to a 4 hr cold challenge at 4C (n = 5).
(G) mRNA expression of Ucp1, Pgc1a, and Dio2 in BAT of 15C acclimatized control and CPT2A/ mice after a 4 hr cold challenge (n = 5).
(legend continued on next page)
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Figure 4. Contribution of Adipose Fatty Acid Oxidation to Energy Expenditure
(A) VO2 consumption of control and CPT2A/ male mice treated with 10 mg/kg CL-316243.
(B) Food intake of control and CPT2A/ mice.
(C) Water intake of control and CPT2A/ mice under ad libitum and fasting under dark and light cycles.
(D) Respiratory exchange ratio of control and CPT2A/ mice under ad libitum and fasting under dark and light cycles.
(E) Energy expenditure of control and CPT2A/ mice under ad libitum and fasting under dark and light cycles.
(F) Ambulation rates of control and CPT2A/ mice under ad libitum and fasting under dark and light cycles (n = 10–14).
Data are expressed as means ± SEM. *p < 0.05. Open bars represent control, and black bars represent loss of CPT2.after 3 hr of cold stimulation. To determine mitochondrial num-
ber, we quantified BAT mitochondrial DNA and found that gWAT
and iWAT maintained normal mitochondrial DNA content
whereas CPT2A/ BAT had about a 2-fold suppression in mito-
chondrial DNA (Figure 3J). These data show that mitochondrial
long-chain fatty acid oxidation in BAT is important not only for
cellular bioenergetics but also for nuclear-encoded mitochon-
drial gene expression, mitochondrial protein abundance, and
density.
Bioenergetic Contribution of Adipose Fatty
Acid Oxidation
In the absence of cold stimulation, it was not clear what the
contribution of adipose fatty acid oxidation is to whole-body en-
ergy expenditure under standard physiological conditions or
perturbations. To determine the physiological contributions of
adipose fatty acid oxidation, we housed control and CPT2A/
mice individually in metabolic cages and measured metabolic
parameters continuously during ad libitum feeding and fasting
conditions. Consistent with a requirement for fatty acid oxidation
during cold exposure, an injection of CL-316243 rapidly in-
creased oxygen consumption in control mice but was com-
pletely ineffective in altering oxygen consumption in CPT2A/(H) mRNA expression of Ucp1, Pgc1a, and Dio2 in BAT of control and CPT2A/m
3 hr (n = 4–5).
(I) Western blot of mitochondrial proteins in BAT of control and CPT2A/ mice a
(J) Mitochondrial DNA content of BAT and gWAT from control and CPT2A/ mic
Data are expressed as mean ± SEM. *p < 0.01; **p < 0.05. Open bars represent
Cmice (Figure 4A). Unlike other models where changes in fatty
oxidation drive changes in feeding behavior (Abu-Elheiga et al.,
2001), CPT2A/mice had no changes in food intake compared
to control mice (Figure 4B). Interestingly, CPT2A/ mice con-
sumed more water than controls during the course of the exper-
iment, particularly during fasting (Figure 4C). This suggests that
adipose tissue fatty acid oxidation may play a role in the gener-
ation and balance of water, similar to the role of lipid oxidation
during hibernation (Nelson et al., 1973). There were minor reduc-
tions in energy expenditure and increased respiratory exchange
ratio in CPT2A/ mice relative to controls (Figures 4D and 4E).
Additionally, there was a modest increase in ambulatory activity
in CPT2A/ mice that may reflect a compensatory requirement
of energy expenditure from skeletal muscle (Figure 4F). These
data show that adipose fatty acid oxidation contributes to overall
energy expenditure in the absence of cold stimulation, albeit
minimally.
Loss of Adipose Fatty Acid Oxidation Results in Diet-
Dependent Changes in Adiposity, but Not Body Weight
It has been suggested that mitochondrial dysfunction and
suppressed BAT or WAT fatty acid oxidation contributes to
changes in body weight and glucose tolerance (Keaney et al.,ice acclimatized to 30C and injected with vehicle or 10 mg/kg CL-316243 for
t 21C or after 3 hr at 4C.
e (n = 10–12).
control, and black bars represent loss of CPT2.
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Figure 5. The Loss of Adipose Fatty Acid Oxidation Affects Diet-Dependent Adiposity, but Not Body Weight
(A) Body weights of control and CPT2A/ male mice fed a low or high fat diet (n = 13–18).
(B) H&E-stained sections of gWAT from control and CPT2A/ mice fed low- or high-fat diets. Scale bar is 250 mM.
(C) Body compositions measured by EchoMRI for control and CPT2A/ mice fed low- or high-fat diets (n = 13–18).
(D) Wet weights of iWAT and gWAT unilateral depots for control and CPT2A/ mice fed low- or high-fat diets (n = 13–18).
(E) Serum metabolites in control and CPT2A/ mice fed low- or high-fat diets (n = 8).
Data are expressed as means ± SEM. **p < 0.01; *p < 0.05. Open bars represent control, and black bars represent loss of CPT2.2003; Kusminski and Scherer, 2012). CPT2A/ BAT is both bio-
energetically and transcriptionally unable to support thermogen-
esis. Additionally, we have shown that the oxidation of fatty acids
in adipose tissue is not a major determinant of whole-animal bio-
energetics during ad libitum or fasting conditions. To determine
the consequences of a chronic long-term inability to oxidize fatty
acids in adipocytes on body weight, we placed control and
CPT2A/mice on matched low- and high-fat diets for 12 weeks
and measured their body weights weekly. CPT2A/ mice eli-
cited no change in body weight, compared to control littermates,
fed either a high-fat or low-fat diet (Figure 5A). Evaluation of fat272 Cell Reports 10, 266–279, January 13, 2015 ª2015 The Authorsand lean content revealed a 64% increase in fat mass in low-
fat-fed CPT2A/ mice (Figures 5B and 5C). Measurement of
fat pad weights of low-fat-fed CPT2A/ mice showed 67% in-
creases in both gonadal and inguinal fat pads (Figure 5D).
High-fat-fed CPT2A/ mice displayed a suppression of fat
mass that was mainly the result of changes in inguinal adiposity
(Figures 5C and 5D). These seemingly paradoxical results are
actually consistent with other models with dysfunctional adipose
fatty acid oxidation or uncoupling (Ellis et al., 2010; Liu et al.,
2003) and likely reflect compensatory increases in energy
expenditure in tissues other than adipose. The expression of
Figure 6. The Loss of Fatty Acid Oxidation Alters Carbohydrate
Metabolic Flux
(A) De novo lipogenesis of control and CPT2A/ liver, gWAT, and BAT from a
1 hr injection of 3H-acetate normalized to tissue wet weight (n = 4–5).
(B) De novo lipogenesis of control and CPT2A/ MEFs from 3H-acetate or
2-14C-pyruvate normalized to protein concentration (n = 6).
(C) Substrate oxidation of control and CPT2A/MEFs from 2-14C-pyruvate or
U-14C-glucose normalized to protein concentration (n = 5).
Data are expressed as mean ± SEM. *p < 0.05. Open bars represent control,
and black bars represent loss of CPT2.
Cfatty acid biosynthetic genes was largely unchanged between
control and CPT2A/ gWAT; however, there were increases in
fatty acid oxidative genes Cpt1a and Mlycd in low-fat-fed
CPT2A/ gWAT (Figure S2A). This suggests distinct regulatory
mechanisms in CPT2A/ BAT and gWAT, since Cpt1b and
Mlycd were decreased in CPT2A/ BAT. Consistent with
increased compensatory energy expenditure, high-fat-fed
CPT2A/ mice displayed about a 2-fold increase in circulating
ketones compared to control high-fat-fed mice (Figure 5E).
Analysis of gene expression in iWAT and liver of control and
CPT2A/ mice shows that under high-fat conditions, many of
the changes between the genotypes were concentrated in the
iWAT (Figure S2B). Conversely, liver from control and CPT2A/
mice showedmost differences after low-fat feeding (Figure S2C).
This shows that individual tissues and even different adipose de-
pots respond disparately. These data demonstrate that the loss
of adipose fatty acid oxidation does not contribute to changes in
total body weight regardless of dietary lipid content, but that
CPT2A/ mice displayed differences in adiposity that were
diet dependent.
Loss of Adipose Fatty Acid Oxidation Is Compensated
in Part by Altered Carbohydrate Metabolism
The diet-dependent changes in adiposity in CPT2A/ mice are
consistent with other cold-intolerant models (Ellis et al., 2010;
Liu et al., 2003). Nonetheless, we were interested in determining
the flux of macronutrients in tissues lacking CPT2. First, we
directly tested the ability of CPT2A/mice to fully oxidize radio-
labeled 1-14C oleic acid in vivo. Consistent with the indirect calo-
rimetry data, we did not observe differences in whole-body fatty
acid oxidation between control and CPT2A/ mice (Figure S3).
Next, we determined the rate of de novo fatty acid synthesis
by injecting 3H-acetate to control and CPT2A/ mice for 3 hr
and extracting lipids from liver, gWAT, and BAT. Although the
livers of control and CPT2A/ mice had equal incorporation of
3H-acetate into lipids, both gWAT and BAT had an 2-fold in-
crease in incorporation (Figure 6A). This suggested that there
was an increase in carbohydrate utilization in cells where CPT2
was deleted. Therefore, we assayed 3H-acetate incorporation
into lipids in control and CPT2KO MEFs. Consistent with the
in vivo data, CPT2KOMEFs had a 2-fold increase in de novo lipo-
genesis from both 3H-acetate and 2-14C-pyruvate (Figure 6B).
Additionally, we examined the oxidation of radiolabeled 2-14C-
pyruvate and U-14C-glucose to 14CO2. While pyruvate oxidation
was increased 20%, glucose oxidation was increased 2-fold
over control cells (Figure 6C). These data show that the loss of
fatty acid oxidation is compensated in part by increased carbo-
hydrate flux.
Adipose Fatty Acid Oxidation Potentiates High-Fat
Diet-Induced Oxidative Stress and Inflammation
The oxidation of fatty acids generates a substantial oxidative
burden. It has been previously demonstrated that high-fat
feeding increases oxidative stress and damaging oxidative end
products particularly within gWAT (Furukawa et al., 2004). Given
the role of fatty acid oxidation in the generation of ROS, we pro-
filed genes known to be involved in oxidative stress in high-fat-
fed control and CPT2A/ gWAT by quantitative PCR (qPCR)ell Reports 10, 266–279, January 13, 2015 ª2015 The Authors 273
Figure 7. Adipose Fatty Acid Oxidation Potentiates High-Fat-Induced Oxidative Stress and Inflammation
(A) Quantitative RT-PCR (qRT-PCR) of oxidative stress genes from gWAT of control and CPT2A/ mice fed a low- or high-fat diet (n = 8).
(B) qRT-PCR of adipokines from gWAT of control and CPT2A/ mice fed a low- or high-fat diet (n = 8).
(C) qRT-PCR of inflammatory genes from gWAT of control and CPT2A/ mice fed a low- or high-fat diet (n = 8).
(D) TBARS assay from gWAT and serum of control and CPT2A/ mice fed a low- or high-fat diet (n = 5).
(legend continued on next page)
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array.Multiple genes involved in detoxifying ROSwere increased
and several more involved in generating ROS were suppressed
(Figure S4). To confirm and extend this data, we analyzed the
genes and pathways identified in the qPCR screen in gWAT
RNA isolated from both low- and high-fat-fed control and
CPT2A/mice. Sod1 and Sod2 trended toward an increase un-
der high-fat conditions, and Sod2 was significantly increased
2-fold in low-fat-fed CPT2A/ gWAT. Genes that increase
oxidative stresswere suppressed in CPT2A/ gWAT specifically
in high-fat-fed conditions (Figure 7A). Therefore, CPT2A/
gWAT gene expression was consistent with greater ROS detox-
ification and lower ROS generation. This led us to look at the
mRNA abundance of adipokines, cytokines, and inflammatory
markers in gWAT of control and CPT2A/ mice. Cox2 mRNA
abundance, which produces inflammatory mediators, was
robustly suppressed in high-fat-fed CPT2A/ gWAT compared
to controls (Figure 7A). Adiponectin mRNA abundance, which
is regulated by redox and suppressed in diabetes, rebounded
in high-fat-fed CPT2A/ gWAT back to low-fat-fed levels
(Figure 7B). Although LeptinmRNA abundance in gWAT was un-
changed between genotypes, Fgf-21 and Adipsin were signifi-
cantly suppressed in low-fat-fed CPT2A/ mice (Figure 7B).
Since Adipsin, also known as complement factor D, is involved
in the inflammatory response, we next looked at inflammatory
markers in CPT2A/ gWAT. Although, the macrophage marker
F4/80 was unchanged between CPT2A/ and control mice,
there was a suppression in Cd11b (Mac-1), a marker for acti-
vatedmacrophages, in high-fat-fed CPT2A/ gWAT (Figure 7C).
Consistent with these changes, there was amarked suppression
in inflammatory gene expression as evidenced by lower mRNA
abundance of Mip-1a and Il-1b, as well as a trend for the sup-
pression in Mip1b in high-fat-fed CPT2A/ gWAT (Figure 7C).
Additionally, the mRNA abundance of the anti-inflammatory
cytokine Il-10 was significantly suppressed in high-fat-fed
CPT2A/ gWAT. There were no changes in the mRNA abun-
dance of several important inflammatory and insulin-resis-
tance-promoting cytokines/chemokines Tnf-a, Il-6, or Mcp1 in
control and CPT2A/ gWAT (Figure 7C). Finally, we measured
oxidized lipids in gWAT and serum of low- and high-fat-fed con-
trol and CPT2A/ mice. The high-fat diet-induced increase in
lipid peroxidation observed in control gWAT and serum was
repressed in CPT2A/ mice (Figure 7D). These data show that
high-fat feeding requires mitochondrial oxidation to potentiate
high-fat diet-induced oxidative stress and inflammation.
Improvements in CPT2A/ Adipose Tissue Oxidative
Stress Did Not Lead to Improved Systemic Glucose
Tolerance
Adipose oxidative stress and inflammation induced by high-fat
feeding has been suggested to initiate a cascade that leads to
systemic insulin resistance (Glass and Olefsky, 2012; Hotamisli-
gil, 2010). Because we have greatly suppressed oxidative stress
and improved inflammatory markers in CPT2A/ mice fed a(E) Intraperitoneal glucose tolerance test (ipGTT) and intraperitoneal insulin tole
respectively, for control and CPT2A/ mice fed a low-fat diet (n = 9).
(F) ipGTT and ipITT including area under the curve and area above the curve, res
Data are expressed as mean ± SEM. **p < 0.005; *p < 0.05.
Chigh-fat diet, we determined glucose tolerance for control and
CPT2A/ mice fed both low- and high-fat diets by glucose
and insulin tolerance tests. Consistent with an increase in
adiposity, low-fat-fed CPT2A/ mice exhibited greater glucose
intolerance exhibited by impaired glucose disposal during the
glucose tolerance test (GTT) and a strong trend toward impaired
glucose clearance in response to insulin in the ITT (Figure 7E).
These defects in glucose tolerance are not seen in chow-fed
mice, suggesting that the high content of simple sugars (i.e., su-
crose) promote lipid deposition and glucose intolerance in adi-
pose in the absence of fatty acid oxidation (Figure S5). In
contrast, high-fat-fed control and CPT2A/ mice had similar
glucose dynamics (Figure 7F). Therefore, the improvements in
adiposity, oxidative stress, and inflammation in high-fat-fed
CPT2A/ mice were not sufficient to reverse systemic insulin
resistance and glucose intolerance and are not consistent with
a requirement for adipose-derived ROS in mediating systemic
glucose intolerance.
DISCUSSION
Obesity is the result of energy imbalance. As caloric intake ex-
ceeds expenditure, metabolic flux is directed into energy re-
serves, primarily as triglyceride in adipose tissue. Conversely,
when caloric expenditure exceeds intake, these reserves are
mobilized to provide physiological fuel. Alterations in adipo-
cyte-specific metabolism can lead to systemic changes in
adiposity, body weight, and glucose tolerance (Abel et al.,
2001; Ahmadian et al., 2011; Lodhi et al., 2012; Vernochet
et al., 2012). The suppression of adipocyte fatty acid oxidation
is often invoked as a mechanism to explain mouse models that
are obese in the absence of increased food intake. Although
this is not an implausible idea, it has lacked an experimental un-
derpinning. Contrary to this notion, we have shown that the lack
of adipocyte long-chain fatty acid oxidation does not lead to
changes in body weight under standard laboratory conditions
even when challenged by calorically dense diets.
BAT can dramatically increase metabolic rate and dissipate
large amounts of stored lipids in a relatively short time once acti-
vated. Transgenic mice with increased BAT mass correlate
nicely with resistance to weight gain (Harms and Seale, 2013).
The transplantation of large amounts of BAT into mice improves
their glucose tolerance but does little to improve their body
weight (Stanford et al., 2013). This may point to a robust endo-
crine rather than bioenergetic contribution of BAT. In fact, in the
absence of cold-induced activation, the role of brown adipocyte
bioenergetics in obesity remains controversial (Kozak, 2010).
Similar to CPT2A/mice, UCP1KO mice are resistant to, rather
than prone to, diet-induced obesity at 20C (Liu et al., 2003). Ag-
ing or a thermoneutral environment can alter this phenotype to
produce obese-prone UCP1KO mice (Feldmann et al., 2009;
Kontani et al., 2005). Additionally, the loss of ACSL1 in adipo-
cytes, which renders mice unable to efficiently activate fattyrance test (ipITT) including area under the curve and area above the curve,
pectively, for control and CPT2A/ mice fed a high-fat diet (n = 13–18).
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acids for oxidation, leads to an increase in adiposity with low-fat
feeding similar to CPT2A/mice (Ellis et al., 2010). Activation of
catabolic processes in tissue other than adipose, needed to
maintain body temperature, likely accounts for their lack of
body-weight change and altered adiposity (Bal et al., 2012).
These experiments illuminate a compensatory role of basal
metabolic rate to compensate for the loss of BAT mediated
thermogenesis; however, little is known about how the basal
metabolic rate is regulated, where it emanates from, or mecha-
nistically how it contributes to body temperature or body
weight.
The phosphorylation of CREB by adrenergic stimulation in-
duces the robust expression of thermogenic genes in BAT,
including Ucp1 and Pgc1a. Conversely, several nuclear hor-
mone receptors and corepressors such as LXRa and RIP140
negatively regulate thermogenic genes (Leonardsson et al.,
2004; Wang et al., 2008). LXRa selectively represses Ucp1 in-
duction by binding adjacent to CREB on the Ucp1 promoter.
The crosstalk between fatty acid metabolism and thermogenic
programing is likely mediated by fatty acid metabolites acting
as ligands for nuclear hormone receptors to suppress agonist-
induced transcriptional control. The fact that ACSL1A/ mice
are cold intolerant but still retain thermogenic gene induction
suggests the defect in CPT2A/ BAT gene expression lies
between the activation of fatty acids and their oxidation (Ellis
et al., 2010). Similar to CPT2A/ mice, systemic carnitine defi-
ciency also results in a suppression of Ucp1 expression in BAT
(Ozaki et al., 2011). These data suggest that an accumulation
of fatty acid metabolites, such as long chain acyl-CoAs, for
example, may be critical nuclear hormone ligands acting as
negative metabolic feedback sensors to link metabolic capacity
to nuclear encoded mitochondrial gene expression.
Although CPT2A/ mice were unable to generate heat or
oxidize fatty acids in BAT and WAT, they did not have changes
in body weight when fed standard chow, low-fat, or high-fat di-
ets. Under low-fat feeding, the mice gained more adiposity,
but this was likely due to the high sucrose content in the diet,
as chow feeding did not elicit increased adiposity. Low-fat-fed
mice have enhanced de novo fatty acid synthesis in WAT, likely
in part due to decreased concentrations of cellular L-carnitine
and acetylcarnitine. Lower L-carnitine and acetylcarnitine levels
can shift mitochondria to increased de novo lipogenesis by the
inability to dissipate mitochondrial acetyl-CoA and thereby its
allosteric effects on the pyruvate dehydrogenase complex and
pyruvate carboxylase (Muoio et al., 2012). High-fat feeding eli-
cited a suppression in adiposity in CPT2A/ mice and a
concomitant 2-fold increase in circulating ketones. Severe
forms of cold intolerance such as ACSL1A/, CPT2A/ mice,
and UCP1KO mice are either neutral or mildly resistant to high-
fat diet-induced obesity at room temperature (Ellis et al., 2010;
Liu et al., 2003). However, mouse models with mild cold intoler-
ance are obese prone at room temperature (Liu et al., 2014;
Mu¨ller et al., 2013). One possible explanation for this paradox
is that mild BAT dysfunction may evade the reflexive compensa-
tion required to maintain body temperature, resulting in
increasedweight gain. Long-term housing ofmice at thermoneu-
trality may relieve this compensation and generate obese-prone
CPT2A/mice similar to UCP1KO mice (Feldmann et al., 2009).276 Cell Reports 10, 266–279, January 13, 2015 ª2015 The AuthorsIt is not clear, however, what the role of uncoupling and heat gen-
eration is at thermoneutrality. Is there still a need for BAT thermo-
genesis, or is uncoupling required for something else entirely,
such as the generation of metabolic water (Neess et al., 2013;
Nelson et al., 1973)?
It is clear that fatty acid oxidation is important in BAT; however,
how does fatty acid oxidation in WAT contribute? The high
oxidative stress and inflammation seen after long-term high-fat
feeding has been attributed to fatty acid metabolism, which we
confirm here (Furukawa et al., 2004). Here, we have evidence
that the rate setting step in fatty acid oxidation is transcriptionally
upregulated 6-fold in high-fat-fed gWAT (Figure S2A). We also
observed increases in oxidative stress and inflammation under
a high-fat diet, and these changes are greatly reduced in the
absence of adipose fatty acid oxidation. Systemic glucose intol-
erance attributed to local adipose dysfunction was not, however,
ameliorated by the loss of CPT2. We observed a suppression in
gWAT inflammation in CPT2A/ mice, as evidenced by a sup-
pression in Cd11b, Cox2, Mip1a, and Il1b. The major and likely
most relevant inflammatory mediators for insulin resistance
such as Tnf-a andMcp1, for example, were unchanged (Hotami-
sligil, 2010). Therefore, these important mediators of obesity-
induced insulin resistance were not dependent on adipose mito-
chondrial long-chain fatty acid b-oxidation.
In summary, adipose tissue fatty acid oxidation is critical for
acute adaptation to the cold by providing both the energy
required to fuel heat generation and the transcriptional regulation
of BAT thermogenesis. Additionally, white adipose fatty acid
oxidation potentiates high-fat diet-induced oxidative stress
and inflammation; however, the improvements seen in
CPT2A/ mice were not sufficient to reverse systemic insulin
resistance. Taken together, adipose fatty acid oxidation is an
important metabolic process for environmental and nutritional
homeostasis.EXPERIMENTAL PROCEDURES
Animals and Diets
CPT2lox/lox mice were generated by targeting loxP sequences to introns flank-
ing exon 4 of the mouse Cpt2 gene by homologous recombination in C57Bl/6
embryonic stem cells by standard methods. To produce mice with a loss
of CPT2 specifically in adipocytes, we bred CPT2lox/lox mice to adiponectin-
Cre transgenic mice (Eguchi et al., 2011). CPT2A/ and littermate CPT2lox/lox
mice were housed in a facility with ventilated racks on a 14 hr light/10 hr dark
cycle with access to a standard chow diet (Etruded Global Rodent Diet, Harlan
Laboratories). For the diet study, mice were fed a 10% low-fat (D12450J,
Research Diets) or a 60% high-fat diet (D12492, Research Diets) from 6 weeks
to 18 weeks of age (12 weeks on diet). At week 10 of the diet, mice were
subjected to a glucose tolerance test by intraperitoneal injection of glucose
(0.75 g/kg) and measuring tail blood glucose at 0, 15, 30, 60, and 120 min.
At week 11 of the diet, insulin tolerance tests were performed via intraperito-
neal injection of insulin (0.6 U/kg) and measuring tail blood glucose at 0, 15,
30, 60, and 90min (Nova Max Plus). Body weights were measured on a weekly
basis. For thermogenesis experiments, 12-week-oldmice had food withdrawn
for 4 hr and placed in a 4C environment for 3 hr. Body temperature was
measured hourly by a rectal probe thermometer (BAT-12, Physitemp). BAT,
iWAT, gWAT, liver, and muscle were collected and frozen in liquid nitrogen.
Serum was collected from all mice, and free glycerol and TAG (Sigma), b-hy-
droxybutyrate (StanBio), total cholesterol (Wako), and NEFA (Wako) were
measured colorimetrically. BAT collected from thermogenesis experiments
was homogenized in Media I (10 mM Tris [pH 8.0], 1 mM EDTA, and 0.25 M
sucrose) to measure TAG (Sigma). For in vivo studies, 20-week-old CPT2A/
and littermate CPT2lox/lox mice were injected with CL-316243 (10mg/kg, Santa
Cruz) or vehicle. To determine the protein expression of phospho-CREB,
CREB, phospho-mTOR and mTOR, CL-316243 (10 mg/kg) or vehicle was in-
jected to 20-week old mice and tissues were collected after 30min. For cold
acclimation, 12–14 week old CPT2A/ and littermate CPT2lox/lox mice were
housed in an animal incubator at 18C on a 12 hr light/12 hr dark cycle with ac-
cess to a standard chow diet for one week. The incubator was lowered to 15C
the following week. Then mice had food withdrawn for 4 hr and placed in a 4C
environment for 4 hr. For thermoneutral adaptation, 12-week-old CPT2A/
and littermate CPT2lox/lox mice were housed in an animal incubator at 30C
on a 12 hr light/12 hr dark cycle with access to a standard chow diet for
2 weeks. At 14 weeks of age, the mice were injected with either CL-316243
(10 mg/kg) or vehicle for 3 hr. All procedures were performed in accordance
with the NIH’s Guide for the Care and Use of Laboratory Animals and under
the approval of the Johns Hopkins Medical School Animal Care and Use
Committee.
Body Composition and Metabolic Analysis
Body fat and lean mass were determined by magnetic resonance imaging
(minispec MQ10) in 18-week-old mice. To measure whole-animal energy utili-
zation, 12-week-old male CPT2A/ and CPT2lox/lox littermates that were fed a
standard chow diet were individually housed in Comprehensive Laboratory
Animal Monitoring System (Columbus Instruments) cages on a 12 hr light/
12 hr dark cycle. O2 and CO2 consumption and production, respectively,
food and water intake, and home-cage activity were measured continuously.
After a 2-day acclimation period, data were collected for 48 hr for ad libitum
and a 24 hr fasting period. At the end of the study, the samemice were injected
with CL-316243 (10 mg/kg) and were monitored for 3 hr.
In Vivo Acetate Incorporation Experiment
Six-week-old CPT2A/ and littermate CPT2lox/lox micewere fed a 10% low-fat
diet for 2 weeks. At 8 weeks of age, mice were injected with 10 mCi of [3H] ac-
etate for 3 hr. BAT, gWAT, and liver were collected, and lipid was extracted us-
ing the Folch method. Aliquots of the samples were counted for [3H] labeled
lipids. All samples were counted using the Beckman Coulter scintillation
counter (LS 6000SC, Beckman Coulter).
Cell Culture
CPT2lox/lox primary MEFs were derived from embryos and cultured in Dulbec-
co’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine
serum (FBS) and 1% penicillin/streptomycin. To generate CPT2lox/lox and
CPT2KO MEFs, cells were first transduced with large T antigen-expressing
lentiviral particles (LVP016-Neo, GenTarget) for 48 hr and G418 (300 mg/mL)
was added to select for positive cells. The selected cells were then transduced
with red fluorescent protein (LVP023, GenTarget) or CRE-2A-RFP (LVP013,
GenTarget) lentiviral particles and selected with blasticidin (10 mg/mL) to
generate CPT2lox/lox and CPT2KO MEFs, respectively.
MEFs were plated in T25 flasks at 70% confluency and incubated in DMEM
supplemented with 10% FBS and 1% penicillin/streptomycin overnight. The
cells were washed with 13 PBS and the reaction mixture for [U-14C] glucose
(DMEM [A14430-01], 2 mM glutamine, 2.5 mM glucose, 0.5 mM sodium pyru-
vate, 0.1 mCi of [U-14C] glucose) or [2-14C] pyruvate (DMEM [A14430-01], 2mM
glutamine, 2.5 mM glucose, 0.5 mM sodium pyruvate, 0.1 mCi of [2-14C] pyru-
vate) was added to cells. The flasks were sealedwith a rubber stopper contain-
ing a hanging well filled with filter paper and incubated in a 37C incubator for
4 hr. Carbon dioxide was trapped by adding 150 ml of 1 M NaOH to the filter
paper in the center well and 200 ml of 1 M perchloric acid to the reaction
mixture. Then the samples were incubated at 55C for 1 hr and the filter paper
was placed in scintillation fluid and counted. For [1-14C] oleate oxidation, the
reaction mixture (DMEM supplemented with 0.1 mCi of [1-14C] oleate,
100 mM L-carnitine hydrochloride [Sigma], and 0.2% BSA) or the reaction
mixture containing 100 mM etomoxir was added to cells and incubated in a
37C incubator for 4 hr. Carbon dioxide was collected and counted as
described above. For [1-14C] lignoceric acid oxidation, the reaction mixture
(DMEM supplemented with 0.1 mCi of [1-14C] lignocerate and 0.2% BSA)Cwas added to cells and incubated overnight in a 37C incubator. Carbon diox-
ide was collected and counted as described above.
For substrate flux into lipids, MEFs were plated in 24-well plates and incu-
bated in DMEM supplemented with 10% FBS and 1% penicillin/streptomycin
overnight and washed with 13 PBS the next day. The cells were incubated in
[2-14C] pyruvate (DMEM [A14430-01], 2 mM glutamine, 2.5 mM glucose,
0.5 mM sodium pyruvate, 0.1 mCi of [2-14C] pyruvate) or [3H] acetate (DMEM
supplemented with 0.3 mCi [3H] acetate) reaction mixture and incubated at
37C for 4 hr. Lipid was extracted using the Folch method, and aliquots of
the samples were counted for [3H]-labeled lipids.
Adipose Tissue Oxidation Experiments
BAT, iWAT, and gWAT were collected from 20-week-old CPT2A/ and litter-
mate CPT2lox/lox male mice and placed in an incubation chamber containing
the reaction mixture (DMEM supplemented with 0.1 mCi of [1-14C] oleate,
100 mM L-carnitine (Sigma), and 0.2% BSA). The chamber contained a center
well filled with filter paper and sealed with a rubber stopper. The incubation
chambers were in a 37C shaking water bath for 4 hr. Trapping carbon dioxide
was collected as described above. In vivo fatty acid oxidation was carried out
as previously described (Reamy and Wolfgang, 2011; Rodriguez and Wolf-
gang, 2012).
BAT Explant Experiments
BAT was collected from 20-week-old mice. Each BAT nugget was cut in half
and placed in media (DMEM, 10% FBS, 200 mM total of palmitate and oleate
at a 1:2 molar ratio, BSA at a 1:3 molar ratio with total fatty acids). Forskolin
(10 mM, Sigma), isoproterenol (10 mM, Sigma), or CL-316243 (10 mM, Santa
Cruz) was added to tubes and incubated in a 37C water bath for 3 hr. The tis-
sues were frozen in liquid nitrogen for further analysis.
Analysis of Gene Expression and Mitochondrial DNA by
Quantitative PCR
Total RNA was isolated using the RNeasy Mini Kit (QIAGEN). A total of 1–2 mg
of RNA was reverse transcribed using the High Capacity cDNA Reverse Tran-
scription Kit (Applied Biosciences). The cDNA was diluted to 2 ng/mL and was
amplified by specific primers in a 20 ml reaction using SsoAdvanced SYBR
Green Supermix (Bio-Rad). WAT cDNA from CPT2A/ and littermate
CPT2lox/lox mice on a high-fat diet was prepared according to the manufac-
turer’s protocol for the mouse oxidative stress PCR array (SA Biosciences).
Analysis of gene expression was carried out in a CFX Connect Real-Time Sys-
tem (Bio-Rad). For each gene, mRNA expression was calculated as 2^deltaCT
relative to cyclophilin A expression. For mitochondrial DNA analysis, total DNA
was prepared using the QIAmp DNA mini Kit (QIAGEN). Mitochondrial DNA
was amplified using primers Co1 and Nd1 and was normalized to genomic
DNA by primers amplifying H19 from genomic DNA as previously described
(Ellis et al., 2011). Primers and gene information are provided in Table S1.
Western Blot Analysis
BAT collected after acute CL-316243 or vehicle injection was homogenized in
13 RIPA buffer with protease inhibitors (Complete Mini, Roche) and phospha-
tase inhibitors (PhosSTOP, Roche). All other tissues from the diet study were
homogenized in 13 RIPA buffer with protease inhibitors (Complete Mini,
Roche). BAT, gWAT, iWAT, and liver samples from thermogenesis experi-
ments were homogenized in Media I with protease inhibitors. All samples
were spun down at 10,000 rpm for 20 min, and supernatant was collected
and assayed by the Pierce BCA Protein Assay Kit (Thermo Scientific) to deter-
mine the concentration of protein. A total of 30 mg of protein was subjected to
SDS-PAGE and transferred to a nitrocellulose membrane (Protran BA 83,
Whatman). The blots were probed with the following antibodies: Uqcrc2 (mito-
profile Total OXPHOS, Abcam), Sdhb (mitoprofile Total OXPHOS, Abcam),
Acsf3 (Pierce), phospho-CREB (Ser-133, Millipore), CREB (Pierce), phos-
pho-mTOR (Cell Signaling), and mTOR (Cell Signaling) using the appropriate
secondary antibodies conjugated to horseradish peroxidase. Fasn (BD Biosci-
ences), Aco2 (Cell Signaling), Mcad (GeneTex), Hsc70 (Santa Cruz), Sod2, and
Hadha (GeneTex) used the appropriate Cy5 (Life Technologies) or Cy3 (Life
Technologies) fluorescent secondary antibodies.ell Reports 10, 266–279, January 13, 2015 ª2015 The Authors 277
Oxidative Damage
Thiobarbituric acid reactive substances (TBARS) were determined in gWAT,
and serum from 20-week-old male CPT2A/ and littermate CPT2lox/lox mice
fed a high- or low-fat diet. WAT was prepared by homogenizing 100 mg of tis-
sue in 500 ml of 13 RIPA buffer with protease inhibitors (Complete Mini,
Roche). Homogenates were centrifuged at 1,600 3 g for 10 min, and 25 ml
of supernatant was used to determine oxidative damage via the TBARS Assay
Kit (Cayman Chemical Company).
Acylcarnitine Analysis
iWAT from CPT2A/ and littermate CPT2lox/lox mice were collected and frozen
in liquid nitrogen. Approximately 100 mg of tissue was analyzed for acylcarni-
tine content at the University of Michigan Metabolomics Core Services.
Statistical Analysis
When only two genotypes were analyzed, statistical significance was deter-
mined using a student’s t test. Two-way ANOVA was utilized for repeated-
measures such as body temperature over time, weight gain over time, GTT,
and insulin tolerance test. Significance was determined for p values < 0.05.
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